CD137L- and RANKL-mediated reverse signals inhibit osteoclastogenesis and T lymphocyte proliferation
- 28 February 2009
- journal article
- Published by Elsevier in Immunobiology
- Vol. 214 (2) , 153-161
- https://doi.org/10.1016/j.imbio.2008.05.001
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Activated T lymphocytes suppress osteoclastogenesis by diverting early monocyte/macrophage progenitor lineage commitment towards dendritic cell differentiation through down-regulation of receptor activator of nuclear factor-kappaB and c-FosClinical and Experimental Immunology, 2006
- The changes in T lymphocyte subsets following periodontal treatment in patients with chronic periodontitisJournal of Periodontal Research, 2006
- T Cells Support Osteoclastogenesis in an In Vitro Model Derived From Human Periodontitis PatientsThe Journal of Periodontology, 2005
- Ligands working as receptors: reverse signaling by members of the TNF superfamily enhance the plasticity of the immune systemCytokine & Growth Factor Reviews, 2004
- Osteoclast differentiation and activationNature, 2003
- Minireview: The OPG/RANKL/RANK SystemEndocrinology, 2001
- Regulation of the differentiation and function of osteoclastsThe Journal of Pathology, 2000
- The Roles of Osteoprotegerin and Osteoprotegerin Ligand in the Paracrine Regulation of Bone ResorptionJournal of Bone and Mineral Research, 2000
- OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesisNature, 1999
- A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell functionNature, 1997